Patheon, Merck Expand Contract Manufacturing Agreement
The expanded agreement solidifies Patheon as a preferred supplier to Merck. Patheon’s projects and services are expected to be delivered to Merck from eight of its global facilities.
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.
Excellagen is a fibrillar bovine Type I collagen-based topical gel (2.6% collagen concentration) that is formulated to include structural stabilizers, hydrolytic enzyme inhibitors, and bacteriostatic agents. Cardium said
proinnovera offers a full range of clinical research services for Phase I-IV clinical trials throughout Europe. proinnovera offers expertise in several therapeutic areas including dermatology, pain management, allergy/respiratory,